Latest Genzyme Stories
Current Neurologist-Reported Patient Share for Tecfidera Exceeds that of Genzyme's Aubagio and Novartis's Gilenya Combined, According to Findings from Decision Resources Group BURLINGTON, Mass.,
LONDON, June 3, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
LONDON, May 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
ROCKVILLE, Md., May 8, 2014 /PRNewswire/ -- Neuralstem, Inc.
- Consistent effects seen across key MRI measures of disease activity; Effects were sustained beyond two-year pivotal MS studies - - Approximately 80 percent of patients treated
PARIS, April 29, 2014 /PRNewswire/ -- Sanofi (NYSE: SNY; EURONEXT: SAN) Q1 2014 Change (reported) Change (CER) Net sales EUR7,842m
PARIS, April 29, 2014 /PRNewswire/ -- Sanofi, a global and diversified healthcare leader, reports results for the first-quarter of 2014.
Market Access Challenges for Sanofi/Genzyme's Aubagio Highlight the Hurdles New Multiple Sclerosis Agents Face in Europe, According to Findings from Decision Resources Group BURLINGTON, Mass.,
For MS Awareness Month, MSAA Launches Effort to Get More People with MS in the Pool CHERRY HILL, N.J., March 18, 2014 /PRNewswire/ -- In honor of Multiple Sclerosis (MS) Awareness Month, the
Minerva president Rogerio Vivaldi and board chairman Marc Beer leading strategy to advance pipeline of novel therapies targeting applications in neuropsychiatry. CAMBRIDGE, Mass., March 5,
- Of or relating to good digestion.